Sharemaestro company-news research for Addex Therapeutics Ltd (ADXN), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
EBS
Switzerland
Measured evidence
Company news sentiment
ADXN news sentiment
Addex Therapeutics Ltd
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone51Neutral is 50
Balanced news tone
36/100 evidence confidence
100% direct company focus
1 current stories across 1 publishers
Current company news
Price moving ahead of tone
Balanced news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.
Latest source headline Addex Therapeutics Ltd (ADXN) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey · 07 Aug 2026 09:18What supports the read
1 current stories are mapped specifically to ADXN.
What tempers the read
Only 1 publisher currently contribute to the measured read.
Price is moving more forcefully than the current news tone suggests.
51/100
Weighted toneBalanced news tone
36/100
Evidence confidencethin evidence
100%/100
Company focus1 direct stories
N/A/100
Evidence agreementrequires at least 2 stories
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth12
1.0 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness35
recency-weighted evidenceAgreement0
requires at least 2 storiesSource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
Price is moving more forcefully than the current news tone suggests.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
Value support
News subjects
What is shaping the score
Market update531 stories · 100%
Source mix
Where the evidence comes from
TradingKey531 stories · 100%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#153Tone
TradingKeyDirect company coverage
Addex Therapeutics Ltd (ADXN) Technical Analysis: Support, Resistance, Indicators & Moving Averages
- Published
- 07 Aug 2026 09:18
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Earlier company news
ADXN news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
Aug
02
2026
TradingKeyArchivedNeutral tone
Addex Therapeutics Ltd (ADXN) Financial Health: Profitability & Balance Sheet Analysis
- Published
- 2 Aug 2026 18:20
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
29
2026
TradingKeyArchivedNegative tone
Addex Therapeutics Ltd (ADXN) Risk Assessment: Volatility, Financial Risk & Investment Risk
- Published
- 29 Jul 2026 01:50
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
24
2026
Stock Traders DailyArchivedNeutral tone
How Addex Therapeutics Ltd (ADXN) Affects Rotational Strategy Timing
- Published
- 24 Jul 2026 16:26
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
24
2026
Simply Wall St.ArchivedNeutral tone
Summit Therapeutics (SMMT) Updates Phase III Survival Data, Is The Stock Still A Bargain?
- Published
- 24 Jul 2026 03:28
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
20
2026
GuruFocusArchivedNeutral tone
Addex Therapeutics (ADXN) Reveals Promising Preclinical Results on Sleep-Wake Regulation
- Published
- 20 Jul 2026 02:58
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
11
2026
Stock TitanArchivedNeutral tone
mGlu7 sleep-wake study featured in Addex Therapeutics (ADXN) Form 6-K filing
- Published
- 11 Jul 2026 09:46
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
07
2026
Stock TitanArchivedNeutral tone
Addex Therapeutics (ADXN) shareholders approve all AGM items and board slate
- Published
- 7 Jul 2026 21:28
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
TradingViewArchivedNeutral tone
Addex Therapeutics Ltd Sponsored ADR Actuals & Estimates (NASDAQ:ADXN)
- Published
- 28 Jun 2026 01:43
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
26
2026
TradingViewArchivedNeutral tone
Addex Therapeutics Ltd Actuals & Estimates (SIX:ADXN)
- Published
- 26 Jun 2026 10:04
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
25
2026
MoomooArchivedNeutral tone
Press Release: Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
- Published
- 25 Jun 2026 02:48
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
GlobeNewswireArchivedNeutral tone
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
- Published
- 22 Jun 2026 20:51
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
21
2026
TradingKeyArchivedNeutral tone
Addex Therapeutics Ltd (ADXN) Valuation: PE, PB & Fair Value Analysis
- Published
- 21 Jun 2026 14:23
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.